ALX Stock Recent News

ALX LATEST HEADLINES

ALX Stock News Image - newsfilecorp.com

Vancouver, British Columbia--(Newsfile Corp. - June 13, 2024) - ALX Resources Corp. (TSXV: AL) (FSE: 6LLN) (OTC: ALXEF) ("ALX" or the "Company") is pleased to announce the results of the 2024 winter drilling program and upcoming summer 2024 exploration plans at its Gibbons Creek Uranium Project ("Gibbons Creek", or the "Project") located in the northern Athabasca Basin near the community of Stony Rapids, Saskatchewan. Gibbons Creek is the subject of an option earn-in transaction with Trinex Lithium Ltd.

newsfilecorp.com 2024 Jun 13
ALX Stock News Image - globenewswire.com

SOUTH SAN FRANCISCO, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today presented data from its Phase 1 ASPEN-07 clinical trial in a poster presentation (abstract #4575) at the 2024 American Society of Cancer Oncology (“ASCO”) Annual Meeting being held in Chicago from May 31-June 4, 2024. These findings represent the first evorpacept combination data with an ADC from ASPEN-07's ongoing, open-label, single-arm, clinical trial of evorpacept in combination with PADCEV (enfortumab vedotin or “EV”) in patients with locally advanced or metastatic urothelial cancer (“la/m UC”). Evorpacept is a CD47 blocker with an inactivated Fc effector domain that is designed to minimize associated toxicity.

globenewswire.com 2024 Jun 02
ALX Stock News Image - globenewswire.com

SOUTH SAN FRANCISCO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced that management will participate in the Jefferies Global Healthcare Conference. Details are as follows:

globenewswire.com 2024 May 29
ALX Stock News Image - newsfilecorp.com

Vancouver, British Columbia--(Newsfile Corp. - May 23, 2024) - ALX Resources Corp. (TSXV: AL) (FSE: 6LLN) (OTC: ALXEF) ("ALX" or the "Company") is pleased to announce it has entered into an amending agreement (the "Amendment") with Denison Mines Corp. ("Denison") whereby ALX may increase its ownership interest in the Hook-Carter Uranium property ("Hook-Carter", or the "Project") from 20% to 25% ownership by funding the next $3.0 million of exploration at the Project within the next 30 months. Hook-Carter is a highly-prospective and large exploration property with significant coverage along the prospective Patterson Lake, Carter, and Derksen exploration corridors — notably covering approximately 13 kilometres of the Patterson Lake Corridor along strike of the Arrow uranium deposit owned by NexGen Energy Ltd.

newsfilecorp.com 2024 May 23
ALX Stock News Image - forbes.com

What's better than a big dividend?

forbes.com 2024 May 19
ALX Stock News Image - Zacks Investment Research

Alexander's (ALX) came out with quarterly funds from operations (FFO) of $4.98 per share, missing the Zacks Consensus Estimate of $6.41 per share. This compares to FFO of $3.63 per share a year ago.

Zacks Investment Research 2024 May 06
ALX Stock News Image - GlobeNewsWire

PARAMUS, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that it will file its quarterly report on Form 10-Q for the quarter ended March 31, 2024 with the U.S. Securities and Exchange Commission and issue its first quarter earnings release on Monday, May 6, 2024, before the New York Stock Exchange opens.

GlobeNewsWire 2024 Apr 25
ALX Stock News Image - Seeking Alpha

Alexander's: Hold On To This 8.8% Yield From New York City

Seeking Alpha 2024 Apr 21
ALX Stock News Image - Zacks Investment Research

ALX, ATLC and DCOM have been added to the Zacks Rank #5 (Strong Sell) List on April 2, 2023.

Zacks Investment Research 2024 Apr 02
ALX Stock News Image - Zacks Investment Research

ACNB, ALX and CYH have been added to the Zacks Rank #5 (Strong Sell) List on March 26, 2023.

Zacks Investment Research 2024 Mar 26
10 of 50